US Patent Issued to TETRAGON BIOSCIENCE on April 21 for "Deoxy-cytidine or uridine derivatives for use in cancer therapies" (Null, Norwegian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,397, issued on April 21, was assigned to TETRAGON BIOSCIENCE LTD. (Modi'in, Israel).

"Deoxy-cytidine or uridine derivatives for use in cancer therapies" was invented by Adam Brian Robertson (Oslo, Norway) and Terezia Prikrylova (Zilina, Slovak Republic).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound of Formula (I): or a stereoisomer, solvate, tautomer or pharmaceutically acceptable salt thereof, wherein X, W1, W2, Y, Z, R1, R2 and R3 are as defined in the disclosure herein, for use in therapy, particularly for use in the treatment of cancer. The present invention also relates to methods of treating cancer ...